A study to evaluate the safety of long-term intake of test food in healthy adult subjects - A study to evaluate the safety of long-term intake of test food in healthy adult subjects

Pharma Foods International Co.,Ltd.0 sites24 target enrollmentJune 9, 2022

Overview

No summary available.

Registry

who.int

Start Date

June 9, 2022

End Date

October 25, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Pharma Foods International Co.,Ltd.

•(1\) Subjects receiving a medical treatment for chronic diseases (dyslipidemia, high blood pressure, diabetes, etc.) (2\) Subjects receiving a medical treatment for serious cardio\-vascular, hepatic, renal, respiratory, endocrine or metabolic disorders or having a medical history of these disorders (3\) Subjects who have the possibility of developing allergic symptoms by the test food (4\) Subjects who take Foods for Specified Health Uses or Foods with Function Claims labeled the effects on lipid metabolism (reducing blood LDL cholesterol, triglycerides, body fat, etc.) (5\) Subjects who take foods having the effects on lipid metabolism (reducing blood LDL cholesterol, triglycerides, body fat, etc.) (6\) Female subjects who are pregnant or lactating, or intending to become pregnant during the study (7\) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) (8\) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study (9\) Subjects deemed unsuitable by the investigator